Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

ClinicalTrials.gov ID: NCT00774345

Public ClinicalTrials.gov record NCT00774345. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 30, 2026, 11:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia Following Second-Line Therapy (The Continuum Trial)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine if lenalidomide (Revlimid®) is safe and effective as a maintenance therapy at improving further the quality of the response you achieved with your last therapy and at prolonging the duration of your response. This study will compare the effects (good and bad) of lenalidomide with the dummy drug.

Study identification

NCT ID
NCT00774345
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Celgene
Industry
Enrollment
317 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 27, 2009 (Actual)
Primary completion
Oct 27, 2020 (Actual)
Completion
Oct 27, 2020 (Actual)
Last update posted
Dec 2, 2021

2009 – 2020

United States locations

U.S. sites
56
U.S. states
23
U.S. cities
51
Facility City State ZIP Site status
Mayo Clinic - Arizona Phoenix Arizona 85054 —
Pacific Coast Hematology Oncology Fountain Valley California 92708 —
Kaiser Permanente Medical Group San Diego California 92120 —
Sharp Memorial Hospital San Diego California 92123 —
Stanford University Stanford Stanford California 94305 —
University of Colorado Hospital Aurora Colorado 80045 —
Rocky Mountain Cancer Center Denver Colorado 80218-1210 —
Cancer Center of Central Connecticut Plainville Connecticut 06062 —
Boca Raton Community Hospital Boca Raton Florida 33486 —
Pasco Hernando Oncology Associates, PA Brooksville Florida 34613 —
Memorial Hospital Hollywood Florida 33021 —
Mayo Clinic - Jacksonville Jacksonville Florida 32224 —
Florida Cancer Specialist Tavares Florida 32778 —
Florida Hospital Cancer Institute Waterman Tavares Florida 32778 —
Augusta Oncology Associates, P.C. Augusta Georgia 30901 —
Northwest Georgia Oncology Centers, PCWilliam S. Gibbons Center Research Institute Marietta Georgia 30060 —
Northwestern University, Division of Hematology Oncology, Dept. of Medicine Chicago Illinois 60611 —
Rush University Medical Center Chicago Illinois 60612 —
Ingalls Memorial Hospital Harvey Illinois 60426-3558 —
Edward Hines Jr VA Hospital Hines Illinois 60141 —
North Chicago VA Medical Center North Chicago Illinois 60064 —
Hematology Oncology Assoc. of IL Orchard Research LLC Skokie Illinois 60076 —
Floyd Memorial Cancer Center of Indiana, a division of Floyd Memorial Hospital and Health Services New Albany Indiana 47150 —
McFarland Clinic Ames Iowa 50010 —
Siouxland Hematology-Oncology Associates, LLP Sioux City Iowa 51101-1733 —
Ochsner Medical Institutions New Orleans Louisiana 70121 —
Clinical Unit for Research Trials in Skin CURTIS Massachusetts General Hospital Boston Massachusetts 02114 —
Nevada Cancer Research Foundation Las Vegas Nevada 89106 —
The Cancer Center, Hackensack University Medical Center Hackensack New Jersey 07601 —
Roswell Park Cancer Institute Buffalo New York 14263 —
Winthrop University Hospital Mineola New York 11501 —
Biomedical Research Alliance of New York, LLC New Hyde Park New York 11042 —
SUNY Upstate Medical University Medicine Oncology Syracuse New York 13215 —
Westchester County Medical Center Valhalla New York 10595 —
Wake Forest Univ. Health Sciences Outpatient Comprehensive Cancer Center Winston-Salem North Carolina 27157 —
Gabrail Cancer Center Research Canton Ohio 44718 —
The Christ Hospital Cincinnati Ohio 45219 —
Oncology Hematology Care Cincinnati Ohio 45242 —
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 —
Cleveland Clinic Cleveland Ohio 44195 —
Hematology Oncology Consultants, Inc. Columbus Ohio 43235 —
Gabrail Cancer Center Research Dover Ohio 44622 —
Trilogy Cancer Care Wooster Ohio 44691 —
Kaiser Permanente Northwest Oncology Hematology Portland Oregon 97227 —
Abington Memorial Hospital Abington Pennsylvania 19001 —
Gettysburg Cancer Center Gettysburg Pennsylvania 17325 —
Drexel University, College of Medicine, Clinical Research Group Philadelphia Pennsylvania 19102 —
Western Pennsylvania Hospital Pittsburgh Pennsylvania 15224 —
Abington Hematology Oncology Associates Inc Willow Grove Pennsylvania 19090 —
Charleston Hematology Oncology P.A. Charleston South Carolina 29403 —
M. Francisco Gonzalez, MD, PA Sumter South Carolina 29150 —
Sarah Cannon Cancer Center Nashville Tennessee 37203 —
UT Southwestern Medical Center Dallas Texas 75390 —
Swedish Cancer Institute Seattle Washington 98104 —
Wenatchee Valley Hospital and Clinics Wenatchee Washington 98801 —
Gundersen Clinic Lutheran Hospital La Crosse Wisconsin 54601 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 185 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00774345, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 2, 2021 · Synced Sep 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00774345 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →